Eight‐color multiparameter flow cytometry (EuroFlow‐NGF) is as sensitive as next‐generation sequencing in detecting minimal/measurable residual disease in autografts of patients with multiple myeloma

Eight‐color multiparameter flow cytometry (EuroFlow‐NGF) is as sensitive as next‐generation sequencing in detecting minimal/measurable residual disease in autografts of patients with multiple myeloma

Abstract The prognostic value of minimal/measurable residual disease (MRD) detection in autografts of patients with multiple myeloma (MM) in an autologous stem‐cell transplantation setting has been reported. Next‐generation flow (NGF) cytometry has lower sensitivity (2 × 10−6) to detect MRD than nex...

Full description

Bibliographic Details
Main Authors: Ryota Urushihara, Naoki Takezako, Takeshi Yoroidaka, Takeshi Yamashita, Ryoichi Murata, Kenji Satou, Shinji Nakao, Hiroyuki Takamatsu
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:eJHaem
Subjects:
autologous peripheral blood stem‐cell transplantation
minimal/measurable residual disease (MRD)
multiparameter flow cytometry
myeloma
next‐generation sequencing
Online Access:https://doi.org/10.1002/jha2.633

Internet

https://doi.org/10.1002/jha2.633

Similar Items